Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling

被引:17
作者
O'Connell, NM
Saunders, RE
Lee, CA
Perry, DJ
Perkins, SJ
机构
[1] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
[2] Royal Free & Univ Coll, Sch Med, Katharine Dormandy Haeophilia Ctr, London, England
[3] Royal Free & Univ Coll, Sch Med, Haemostasis Unit, London, England
关键词
factor XI; homology model; mutations;
D O I
10.1111/j.1538-7836.2004.01088.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Factor (F)XI is important in the consolidation phase of blood coagulation. The structural effects of mutations causing FXI deficiency have not been well described due to the lack of a structure for FXI. Objectives: To develop molecular models of the four apple (Ap) and serine protease (SP) domains in FXI in order to assess the structural effects of published FXI mutations in the light of their phenotypes. Methods: The Ap domains were modeled using the NMR structure of an adhesin from Emeria tenella. The SP domain was modeled using the crystal structure of P-tryptase. Results: The effect of 42 mutations causing FXI deficiency was analyzed using homology models for the Ap and SP domains in FXI. Protein misfolding was implicated as the likely structural mechanism of disease in six of 14 mutations in the four Ap domains with Type I phenotypes. Likewise, misfolding was implicated in eight of 14 mutations in the SP domain with Type I phenotypes. Unlike other coagulation factor deficiencies, Type II phenotypes based on a catalytically dysfunctional FXI are uncommon. The structural models indicated that two known Type II mutations in the Ap domains could be correlated with functional defects in substrate or cofactor binding, and likewise four Type II mutations in the SP domain would disrupt the active site. Conclusions: New FXI disease-causing mutations can now be structurally characterized to complement phenotypic data, and expression studies can be designed to verify the molecular basis of each deficiency.
引用
收藏
页码:127 / 138
页数:12
相关论文
共 80 条
[1]   Identification of a novel mutation in a non-Jewish factor XI deficient kindred [J].
Alhaq, A ;
Mitchell, M ;
Sethi, M ;
Rahman, S ;
Flynn, G ;
Boulton, P ;
Caeno, G ;
Smith, M ;
Savidge, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :44-49
[2]  
Alhaq A, 2000, BLOOD, V96, p80B
[3]   Iterated profile searches with PSI-BLAST - a tool for discovery in protein databases [J].
Altschul, SF ;
Koonin, EV .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (11) :444-447
[4]   ORGANIZATION OF THE GENE FOR HUMAN FACTOR-XI [J].
ASAKAI, R ;
DAVIE, EW ;
CHUNG, DW .
BIOCHEMISTRY, 1987, 26 (23) :7221-7228
[5]   FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL [J].
ASAKAI, R ;
CHUNG, DW ;
DAVIE, EW ;
SELIGSOHN, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :153-158
[6]   RETRACTED: Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa (Retracted article. see vol 282, pg 29067, 2007) [J].
Baglia, FA ;
Walsh, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20514-20519
[7]  
BAGLIA FA, 1991, J BIOL CHEM, V266, P24190
[8]   IDENTIFICATION AND CHARACTERIZATION OF A BINDING-SITE FOR PLATELETS IN THE APPLE-3 DOMAIN OF COAGULATION-FACTOR-XI [J].
BAGLIA, FA ;
JAMESON, BA ;
WALSH, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6734-6740
[9]  
BAGLIA FA, 1992, J BIOL CHEM, V267, P4247
[10]  
Baglia FA, 1996, J BIOL CHEM, V271, P3652